tau 抗体 (pTyr18)
Our Local Distributor
北京 101111
Quick Overview for tau 抗体 (pTyr18) (ABIN2443721)
抗原
See all tau 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 12-24, pTyr18
-
原理
- Phospho-Tau (tyr 18) Mouse Monoclonal Antibody (9G3)
-
特异性
- The antibody recognizes the human Phospho-Tau protein at the tyrosine 18 phosphorylation site with no detectable cross-reactivity.
-
纯化方法
- Protein G purified
-
免疫原
- Peptide
-
亚型
- IgG2a
-
-
-
-
应用备注
- WB 1:1000-1:5000,IHC 1:1000-1:5000,IF 1:2000-1:5000
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- If reconstituted with deionized water in 100 μL: WB 1:1000-1:5000, IHC 1:1000-1:5000, IF 1:2000-1:5000. Optimal dilution has to be determined by the user.
-
缓冲液
- Lyophilized protein G purified in PBS pH 7.4
-
储存液
- Without preservative
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Lyophilized antibodies can be kept at 4°C for up to 3 months and should be kept at -20°C for long-term storage (2 years). To avoid freeze-thaw cycles, reconstituted antibodies should be aliquoted before freezing for long-term (1 year) storage (-80°C) or kept at 4°C for short-term usage (2 months). For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made with the assay buffer. After the maximum long-term storage period (2 years lyophilized or 1 year reconstituted) antibodies should be tested in your assay with a standard sample to verify if you have noticed any decrease in their efficacy. To limit antibody loss or degradation, BSA (final concentration 1%) and sodium azide (final concentration 0.02%) can be added to the suggested first dilution. It is important to first verify if those preservatives are compatible with your assay.
-
有效期
- 24 months
-
-
-
: "Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy." in: Acta neuropathologica communications, Vol. 8, Issue 1, pp. 96, (2020) (PubMed).
-
-
- tau (tau Protein)
-
别名
- tau
-
背景
-
Phosphorylated Tau
Tauopathies are a group of diverse dementias and movement disorders which have a common pathological feature in that they all display the presence of intracellular accumulation of abnormal filaments of Tau protein. While the abnormal phosphorylation of Tau on serine and threonine has been well established in the disease process, its phosphorylation on tyrosine 18 has only recently been described as present in Alzheimer's disease (AD) brain.
-
UniProt
- P10636
抗原
-